Increase your market understanding with new pricing and reimbursement analysis.
Unique one-off reports only available with Datamonitor Healthcare
Due to your feedback we’ve expanded our popular pricing and reimbursement analysis so that they now cover our disease areas – starting with hepatitis C, melanoma and HER2-positive breast cancer. Available as stand alone reports you’re able to immerse yourself into your chosen market and emerge an expert.
It’s becoming increasingly complex to get your drugs reimbursed and understanding the changing dynamics within your disease area is essential to ensuring you maximise the revenue from your products.
“By focusing on a disease area these reports make it so much easier to understand the dynamics of something that’s becoming increasingly difficult to manage. I’m looking forward to seeing what markets you analyse next.” Key opinion leader, 2014
Detailed analysis of key disease areas across 7 major markets ensures you’re as informed as you need to be
- Access detailed analysis for seven major markets
You’re able to optimize your market access strategy with highly detailed disease-specific pricing and reimbursement landscape analysis across the US, Japan and five major EU markets (France, Italy, Spain, UK and Germany).
- Access analysis of past reimbursement decisions
Anticipate future buyer behaviour by looking through our detailed analysis of past reimbursement decisions
- Insight into competitors performance
Make highly informed decisions with insight into how competitors’ products have fared in health technology assessment